Table 4.

Civil society organization HCV activity summary

Category	Activities
Awareness raising	National campaigns to inform decision makers and the general public	Patient ‘schools’ on access to treatment and other HCV issues	Media notices on HCV	Educational videos
Mobilization	Establishing networks of individuals and organizations to advocate HCV issues	Implementing letter writing/petition signing campaigns, e.g. a ‘Treatment Waiting List’ and lower price requests to pharmaceutical companies	Organizing research and reporting on HCV needs	Organizing CSOs to meet with pharmaceutical companies
Advocacy	Encouraging national treatment programs and guideline development	Organizing campaigns aiming to bring about favorable policy and response from governments, industry and donors	Negotiating lower prices with pharmaceutical companies	Specific opposition to pharmaceutical patent applications and support for alternate licensing
Testing and treatment	Conducting screening test campaigns to identify HCV- antibody positive people (that also raise awareness and provide evidence for advocacy)	Implementing treatment programs integrated into existing services, particularly for the disproportionately affected/marginalized, e.g. PWID	Seeking donor funding for expanded treatment programs using updated protocols	Providing community-level and technical input on national program planning and guideline committees

EECA Civil Society Involvement in HCV Work